ACAD FY 2020 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$442M+30.3% YoY

Gross Profit

$421M95.3% margin

Operating Income

-$287M-64.9% margin

Net Income

-$282M-63.7% margin

EPS (Diluted)

$-1.79

Cash Flow

Operating Cash Flow

-$136M

Free Cash Flow

-$144M

Stock-Based Comp.

$84M

Balance Sheet

Total Assets

$783M

Total Liabilities

$156M

Stockholders' Equity

$627M

Cash & Equivalents

$326M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$442M	$339M	+30.3%
Gross Profit	$421M	$319M	+31.8%
Operating Income	-$287M	-$247M	-16.2%
Net Income	-$282M	-$235M	-19.7%